Literature DB >> 18284846

Evaluation of oxidative stress markers in neonates with intra-uterine growth retardation.

Zsuzsanna Hracsko1, Hajnalka Orvos, Zoltan Novak, Attila Pal, Ilona S Varga.   

Abstract

Intra-uterine growth retardation (IUGR) is an abnormality of pregnancy. Neonates with IUGR weigh less than the 10th percentile for gestational age. The objective of the study was to identify the relationship between IUGR and the antioxidant status. Cord blood of 157 neonates with normal weight (control group) and 29 neonates with IUGR were included. The following parameters were determined and compared in the two groups: lipid peroxidation in the plasma, red blood cells and erythrocyte ghosts; protein and DNA damage; antioxidant enzyme activities (superoxide dismutase, catalase, glutathione peroxidase); the level of reduced glutathione; and the ferric reducing ability of the plasma. The level of lipid peroxidation was significantly higher in the IUGR group. The antioxidant enzyme activities and the levels of antioxidants were significantly lower in the IUGR group. Damage of proteins and DNA was slightly, but non-significantly, higher in the IUGR group. Neonates with IUGR seem to have significant deficiencies in antioxidant defence. IUGR is correlated with significant oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284846     DOI: 10.1179/135100008X259097

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  32 in total

1.  The quality of the antioxidant defence system in term and preterm twin neonates.

Authors:  Renáta Lázár; Hajnalka Orvos; Réka Szőllősi; Ilona S Varga
Journal:  Redox Rep       Date:  2014-11-03       Impact factor: 4.412

Review 2.  In utero oxidative stress epigenetically programs antioxidant defense capacity and adulthood diseases.

Authors:  Rita S Strakovsky; Yuan-Xiang Pan
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

3.  Alteration of mitochondrial function in adult rat offspring of malnourished dams.

Authors:  Brigitte Reusens; Nicolas Theys; Claude Remacle
Journal:  World J Diabetes       Date:  2011-09-15

4.  Cord blood 8-isoprostane in the preterm infant.

Authors:  Karen Mestan; Nana Matoba; Lester Arguelles; Candace Harvey; Linda M Ernst; Kathryn Farrow; Xiaobin Wang
Journal:  Early Hum Dev       Date:  2012-03-15       Impact factor: 2.079

5.  Maternal antioxidant blocks programmed cardiovascular and behavioural stress responses in adult mice.

Authors:  Robert D Roghair; John A Wemmie; Kenneth A Volk; Thomas D Scholz; Fred S Lamb; Jeffrey L Segar
Journal:  Clin Sci (Lond)       Date:  2011-11       Impact factor: 6.124

Review 6.  Role of the hypothalamic-pituitary-adrenal axis in developmental programming of health and disease.

Authors:  Fuxia Xiong; Lubo Zhang
Journal:  Front Neuroendocrinol       Date:  2012-11-27       Impact factor: 8.606

7.  Alterations in the antioxidant defense system in prepubertal children with a history of extrauterine growth restriction.

Authors:  M Ortiz-Espejo; M Gil-Campos; M D Mesa; C E García-Rodríguez; M C Muñoz-Villanueva; J L Pérez-Navero
Journal:  Eur J Nutr       Date:  2013-08-08       Impact factor: 5.614

8.  Birth weight and carotid artery intima-media thickness.

Authors:  Julia Dratva; Carrie V Breton; Howard N Hodis; Wendy J Mack; Muhammad T Salam; Elisabeth Zemp; Frank Gilliland; Nino Kuenzli; Ed Avol
Journal:  J Pediatr       Date:  2012-12-20       Impact factor: 4.406

9.  Maternal obesity and malnourishment exacerbate perinatal oxidative stress resulting in diabetogenic programming in F1 offspring.

Authors:  M I Saad; T M Abdelkhalek; M M Haiba; M M Saleh; M Y Hanafi; S H Tawfik; M A Kamel
Journal:  J Endocrinol Invest       Date:  2015-12-14       Impact factor: 4.256

10.  Labor augmentation with oxytocin decreases glutathione level.

Authors:  Naomi Schneid-Kofman; Tali Silberstein; Oshra Saphier; Iris Shai; Dorith Tavor; Ariela Burg
Journal:  Obstet Gynecol Int       Date:  2009-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.